Overview
The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.
Eligibility
Inclusion Criteria:
- Subject or representatives must have voluntarily signed the informed consent form before any study related procedures
- Subjects can be any gender, but must be between (and including) 18 and 75 years of age
- Subject has been on dialysis for more than 90 days and has been diagnosed with end stage kidney disease
- Subject is able and willing to provide informed consent and HIPAA authorization.
- Subject is able and willing to meet all study requirements
- Subject is able to place electrodes on bilateral deltoids and above the pant line on the waist.
Exclusion Criteria:
- Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
- Subject has a personal medical history that includes: Long Q-T syndrome, Cardiac channelopathies, genetic heart defects, Seizures, Acute untreated blood clotting disorders or acute untreated bleeding disorders
- Subject has had a heart transplant.